Leads from the MMWR. National Childhood Vaccine Injury Act: requirements for permanent vaccination records and for reporting of selected events after vaccination.
出版信息
JAMA. 1988 May 6;259(17):2527-8.
PMID:2833628
Abstract
摘要
相似文献
1
2
National Childhood Vaccine Injury Act: requirements for permanent vaccination records and for reporting of selected events after vaccination.
MMWR Morb Mortal Wkly Rep. 1988 Apr 8;37(13):197-200.
3
Guillain-Barré syndrome after vaccination in United States: data from the Centers for Disease Control and Prevention/Food and Drug Administration Vaccine Adverse Event Reporting System (1990-2005).美国疫苗接种后发生的吉兰-巴雷综合征：来自疾病控制与预防中心/食品药品监督管理局疫苗不良事件报告系统的数据（1990 - 2005年）
J Clin Neuromuscul Dis. 2009 Sep;11(1):1-6. doi: 10.1097/CND.0b013e3181aaa968.
4
What you should know about FDA-USP Drug Product Problem Reporting Program.
Pharm Times. 1986 Apr;52(4):101-4, 109.
5
Preface to supplement. Active surveillance of vaccine safety in the US Food and Drug Administration's Mini-Sentinel program: identification of exposures and outcomes.增补前言。美国食品药品监督管理局微型哨兵计划中疫苗安全性的主动监测：暴露因素与结局的识别。
Vaccine. 2013 Dec 30;31 Suppl 10:K1. doi: 10.1016/j.vaccine.2013.10.087.
6
Post-licensure rapid immunization safety monitoring program (PRISM) data characterization.疫苗上市后快速免疫安全性监测项目（PRISM）数据特征描述。
Vaccine. 2013 Dec 30;31 Suppl 10:K98-112. doi: 10.1016/j.vaccine.2013.04.088.
7
Adverse drug reaction reporting.
Am J Gastroenterol. 1987 Apr;82(4):356-7.
8
Postmarketing follow-up: physicians have key role.上市后随访：医生发挥关键作用。
JAMA. 1985 Oct 25;254(16):2217.
9
Vaccine Adverse Event Reporting System--United States.美国疫苗不良事件报告系统
MMWR Morb Mortal Wkly Rep. 1990 Oct 19;39(41):730-3.
10
Vaccine adverse event reporting: the importance of follow-up.疫苗不良事件报告：随访的重要性。
Expert Rev Vaccines. 2005 Aug;4(4):445-8. doi: 10.1586/14760584.4.4.445.
Zotero 插件